Digestive Diseases and Sciences

, Volume 39, Issue 9, pp 1883–1884 | Cite as

Response by O. Bulbena

  • Oriol Bulbena
Letters To The Editor
  • 11 Downloads

Keywords

Public Health 

References

  1. 1.
    Bulbena O, Escolar G, Navarro C, Bravo L, Pfeiffer CJ: Gastroprotective effect of zinc acexamate against damage induced by nonsteroidal antiinflammatory drugs. Dig Dis Sci 38:730–739, 1993PubMedGoogle Scholar
  2. 2.
    Esplugues JV, Bulbena O, Escolar G, Navarro C, Esplugues J: Effects of zinc acexamate on gastric mucosal resistance factors. Eur J Pharmacol 109:145–151, 1985PubMedGoogle Scholar
  3. 3.
    Navarro C, Escolar G, Baños JE, Casanovas LI, Bulbena O: Effects of zinc acexamate on gastric mucosal production of prostaglandin E2 in normal and stressed rats. Prostaglandins Leukotrienes Essent Fatty Acids 33:75–80, 1988Google Scholar
  4. 4.
    Pfeiffer CJ, Bulbena O, Esplugues JV, Escolar G, Navarro C, Esplugues J: Anti-ulcer and membrane stabilizing actions of zinc acexamate. Arch Int Pharmacodyn Ther 285:148–157, 1987PubMedGoogle Scholar
  5. 5.
    Smith SM, Grisham MB, Manci EA, Granger DN, Kvietys PR: Gastric mucosal injury in the rat. Role of iron and xanthine oxidase. Gastroenterology 92:950–956, 1987PubMedGoogle Scholar
  6. 6.
    Escolar G, Navarro C, Galmés JL, Casanovas LI, Bulbena O: Zinc acexamate reduces gastric damage induced by platelet-activating factor. Prostaglandins Leukotrienes Essent Fatty Acids 38:49–53, 1989Google Scholar

Copyright information

© Plenum Publishing Corporation 1994

Authors and Affiliations

  • Oriol Bulbena
    • 1
  1. 1.Department of PharmacologyLab. Viñas, S.A.BarcelonaSpain

Personalised recommendations